Delivery Order SPE2DB20D1100-SPE2DB25FC8K2
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$7.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,992.41, is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of October 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,762.40, is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of March 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The delivery order has a firm fixed price of $10,957.52 and a completion date of May 12, 2025. This award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which...
This is a $5,975.10 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication, with a performance period ending on June 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
This is a $7,387.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4564996305 - DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of June 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,789.82 contract is for the delivery of Dapagliflozin 10 mg tablets. It is not set aside and has an ultimate completion date of June 10, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,907.28 firm fixed-price contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $1,377.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567887206 - DAPAGLIFLOZIN 5 MG TABLET 30S, a medication used to treat diabetes. The award has an ultimate completion date of April 14, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,731.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a $2,665.37 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a prescription medication, with a period of performance through February 7, 2025. The award is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...